Format

Send to

Choose Destination
Cardiorenal Med. 2012 Feb;2(1):52-56. Epub 2012 Jan 26.

A Case of Carcinoid Tumor-Associated Hypercalcemia.

Author information

1
Division of Endocrinology, Diabetes and Metabolism, University of Missouri, Columbia, Mo., USA.

Abstract

Hypercalcemia as a complication of carcinoid tumors is extremely rare. Accordingly, we report the case of a 55-year-old male with metastatic carcinoid tumor and hypercalcemia, which corrected when the patient was treated with octreotide for symptomatic relief of watery diarrhea. The etiology of the hypercalcemia is presumed to be a neoplastic expression of fibroblast growth factor-23, which was found to be inappropriately high-to-normal when other factors such as parathyroid hormone, calcitonin and vitamin D were appropriately low or low-to-normal.

PMID:
22493603
PMCID:
PMC3318931
DOI:
000335673

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
Loading ...
Support Center